EVGN - エボジェン (Evogene Ltd.)


   Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program  2021/11/30 12:00:00 PR Newswire
REHOVOT, Israel, Nov. 30, 2021 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), reported today positive results from pre-clinical studies in its IBD program. In
   Evogene (NASDAQ:EVGN) Downgraded by Zacks Investment Research to Sell  2021/11/26 08:42:41 Transcript Daily
Zacks Investment Research lowered shares of Evogene (NASDAQ:EVGN) from a hold rating to a sell rating in a research note released on Monday, Zacks.com reports. According to Zacks, Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding []
   Evogene (NASDAQ:EVGN) Price Target Cut to $7.00  2021/11/25 10:14:42 Dakota Financial News
Evogene (NASDAQ:EVGN) had its price objective trimmed by Royal Bank of Canada from $8.00 to $7.00 in a research report report published on Wednesday morning, Stock Target Advisor reports. The firm currently has an outperform rating on the biotechnology companys stock. EVGN has been the subject of a number of other research reports. Roth Capital []
   LPL Financial LLC Boosts Position in Evogene Ltd. (NASDAQ:EVGN)  2021/11/22 09:10:43 Dakota Financial News
LPL Financial LLC lifted its holdings in shares of Evogene Ltd. (NASDAQ:EVGN) by 21.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,485 shares of the biotechnology companys stock after purchasing an additional 10,625 shares during the quarter. LPL Financial LLC []
   Evogene (NASDAQ:EVGN) Announces Quarterly Earnings Results  2021/11/18 16:18:43 Dakota Financial News
Evogene (NASDAQ:EVGN) announced its quarterly earnings results on Tuesday. The biotechnology company reported ($0.19) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.17) by ($0.02), MarketWatch Earnings reports. Evogene had a negative net margin of 2,326.70% and a negative return on equity of 38.88%. During the same quarter in the prior year, []
   AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product Candidate  2021/07/06 11:30:00 PR Newswire
REHOVOT, Israel, July 6, 2021 /PRNewswire/ -- AgPlenus Ltd., a company designing effective, sustainable crop protection products by leveraging computational biology and chemistry, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that it has achieved positive
   Agricultural Biotechnology Report 2021: Global Methodology, Research Findings, Size And Forecast To 2025| Evogene Ltd., Monsanto Company, Performance Plants Inc., KWS SAAT SE  2021/07/01 18:37:40 OpenPR
The report on the Global Agricultural Biotechnology Market includes basic research along with a comprehensive study of subjective and quantitative perspectives by various industry experts, leading home pioneers to gain an in-depth understanding of the market and industry practices. Based
   Evogene Announces Ms. Sarit Firon to become Evogene''s Chairperson of the Board  2021/06/23 11:00:00 PR Newswire
REHOVOT, Israel, June 23, 2021 /PRNewswire/ --Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announced today that its Board of Directors has resolved to appoint Ms.
   Evogene: Bullish With Canonic''s Entry Into Israeli Medical Cannabis Markets  2021/06/16 07:26:22 Seeking Alpha
   Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2021 Results - Earnings Call Transcript  2021/05/26 18:32:07 Seeking Alpha
   Evogene: Bullish With Canonic''s Entry Into Israeli Medical Cannabis Markets  2021/06/16 07:26:22 Seeking Alpha
   Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2021 Results - Earnings Call Transcript  2021/05/26 18:32:07 Seeking Alpha
   Shares of Medical Cannabis-Related Evogene Slightly Up On First Quarter Earnings  2021/05/26 16:30:36 Benzinga
Computational biology company Evogene Ltd. (NASDAQ: EVGN ) reported Wednesday its first-quarter financial results with revenue of $333,000, compared to $75,000 in the same period of 2020. Q1 Financial Highlights The companys gross profit for the period amounted to $62,000, which compares to $36,000 in the corresponding quarter of the prior year; The total operating expenses were of $6.32 million, compared to $6.89 million in the same period of 2020; The net loss for the quarter reached $7.1 million, which compares to a loss of $7.2 million in the first quarter of the previous year; Its operating loss for the period was $6.3 million, versus $6.9 million in the same period of 2020; A slightly lowered operating loss could Full story available on Benzinga.com
   Evogene shares rise on Q1 topline beat, cash update  2021/05/26 13:57:28 Seeking Alpha
   Evogene EPS beats by $0.01, beats on revenue  2021/05/26 11:38:40 Seeking Alpha